Ingelvac PCV FLEX

RSS

Withdrawn

This medicine's authorisation has been withdrawn

porcine circovirus vaccine (inactivated)
MedicineVeterinaryWithdrawn

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn at the request of the marketing authorisation holder.

български (BG) (302.02 KB - PDF)

Zobacz

español (ES) (354.71 KB - PDF)

Zobacz

čeština (CS) (398.51 KB - PDF)

Zobacz

dansk (DA) (353.81 KB - PDF)

Zobacz

Deutsch (DE) (356.65 KB - PDF)

Zobacz

eesti (ET) (353.06 KB - PDF)

Zobacz

ελληνικά (EL) (422.14 KB - PDF)

Zobacz

français (FR) (356.76 KB - PDF)

Zobacz

hrvatski (HR) (377.01 KB - PDF)

Zobacz

italiano (IT) (353.82 KB - PDF)

Zobacz

latviešu (LV) (406.74 KB - PDF)

Zobacz

lietuvių (LT) (379.26 KB - PDF)

Zobacz

magyar (HU) (396.03 KB - PDF)

Zobacz

Malti (MT) (409.42 KB - PDF)

Zobacz

Nederlands (NL) (354.93 KB - PDF)

Zobacz

polski (PL) (399.96 KB - PDF)

Zobacz

português (PT) (355.88 KB - PDF)

Zobacz

română (RO) (378.84 KB - PDF)

Zobacz

slovenčina (SK) (399.95 KB - PDF)

Zobacz

slovenščina (SL) (388.87 KB - PDF)

Zobacz

suomi (FI) (352.89 KB - PDF)

Zobacz

svenska (SV) (354.63 KB - PDF)

Zobacz

Product information

български (BG) (711.12 KB - PDF)

Zobacz

español (ES) (810.61 KB - PDF)

Zobacz

čeština (CS) (932.35 KB - PDF)

Zobacz

dansk (DA) (807.39 KB - PDF)

Zobacz

Deutsch (DE) (801.97 KB - PDF)

Zobacz

eesti (ET) (803.1 KB - PDF)

Zobacz

ελληνικά (EL) (1.13 MB - PDF)

Zobacz

français (FR) (922.81 KB - PDF)

Zobacz

hrvatski (HR) (822.66 KB - PDF)

Zobacz

italiano (IT) (806.79 KB - PDF)

Zobacz

latviešu (LV) (957.91 KB - PDF)

Zobacz

lietuvių (LT) (826.73 KB - PDF)

Zobacz

magyar (HU) (938.04 KB - PDF)

Zobacz

Malti (MT) (965.75 KB - PDF)

Zobacz

Nederlands (NL) (902.64 KB - PDF)

Zobacz

polski (PL) (926.02 KB - PDF)

Zobacz

português (PT) (810.56 KB - PDF)

Zobacz

română (RO) (837.75 KB - PDF)

Zobacz

slovenčina (SK) (936.99 KB - PDF)

Zobacz

slovenščina (SL) (973.11 KB - PDF)

Zobacz

suomi (FI) (837.29 KB - PDF)

Zobacz

svenska (SV) (805.16 KB - PDF)

Zobacz

Íslenska (IS) (810.01 KB - PDF)

Zobacz

norsk (NO) (808.14 KB - PDF)

Zobacz
Latest procedure affecting product information:IG/0855/G
24/11/2017

български (BG) (336.55 KB - PDF)

Zobacz

español (ES) (278.67 KB - PDF)

Zobacz

čeština (CS) (308.83 KB - PDF)

Zobacz

dansk (DA) (281.18 KB - PDF)

Zobacz

Deutsch (DE) (281.33 KB - PDF)

Zobacz

eesti (ET) (279.45 KB - PDF)

Zobacz

ελληνικά (EL) (312.94 KB - PDF)

Zobacz

français (FR) (278.12 KB - PDF)

Zobacz

hrvatski (HR) (296.78 KB - PDF)

Zobacz

italiano (IT) (277.07 KB - PDF)

Zobacz

latviešu (LV) (305.14 KB - PDF)

Zobacz

lietuvių (LT) (299.06 KB - PDF)

Zobacz

magyar (HU) (289.49 KB - PDF)

Zobacz

Malti (MT) (304.2 KB - PDF)

Zobacz

Nederlands (NL) (277.85 KB - PDF)

Zobacz

polski (PL) (305.13 KB - PDF)

Zobacz

português (PT) (278.81 KB - PDF)

Zobacz

română (RO) (299.89 KB - PDF)

Zobacz

slovenčina (SK) (303.57 KB - PDF)

Zobacz

slovenščina (SL) (302.35 KB - PDF)

Zobacz

suomi (FI) (275.1 KB - PDF)

Zobacz

svenska (SV) (277.71 KB - PDF)

Zobacz

Íslenska (IS) (277.37 KB - PDF)

Zobacz

norsk (NO) (278.69 KB - PDF)

Zobacz

Product details

Name of medicine
Ingelvac PCV FLEX
Active substance
porcine circovirus type 2 ORF2 protein
International non-proprietary name (INN) or common name
porcine circovirus vaccine (inactivated)
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) code
QI09AA07

Pharmacotherapeutic group

Immunologicals for suidae

Therapeutic indication

For active immunisation of pigs with no PCV2 maternally derived antibodies from the age of 2 weeks against porcine circovirus type 2 (PCV2)

Authorisation details

EMA product number
EMEA/V/C/004645
Marketing authorisation holder
Boehringer Ingelheim Vetmedica GmbH

Binger Strasse 173
55216 Ingelheim am Rhein
Germany

Opinion adopted
16/03/2017
Marketing authorisation issued
24/05/2017
Revision
2

Assessment history

This page was last updated on

Share this page